Answer
Dzuveo (sufentanil citrate) is contraindicated in hypersensitivity to the active substance or any excipient, significant respiratory depression, or pulmonary compromise.
Sources for this answer
- Dzuveo 30mcg Sublingual tabletAguettant Ltd · emc · SmPC §4.3 Contraindications · Version 4Document updated
Sources checked